MS: The Benefit of Early Treatment
Beginning to take medication to treat multiple sclerosis (MS) at the early signs might slow the disease's progression, a new study found.
Red Wine Compound May Help with Alzheimer's
Resveratrol, a compound found in red wine, red grapes, raspberries and dark chocolate, could slow cognitive decline in patients with Alzheimer’s disease, a new study found.
Is Cryotherapy a Cool Trend After All?
Whole-body cryotherapy may not be so cool after all, according to the US Food and Drug Administration (FDA).
New Option for Opioid-Induced Constipation
The US Food and Drug Administration (FDA) has approved an oral tablet formulation for Relistor.
The Impact of Brain Injuries
Traumatic brain injuries (TBIs) with loss of consciousness may have a long-term impact on neurological health, a new study found.
A New Treatment for Essential Tremors
The US Food and Administration (FDA) has approved the first ultrasound device to treat essential tremors.
The Link Between Obesity and MS
Obesity in early adulthood may be linked to an increased risk of multiple sclerosis (MS), a new study found.
The Price of Complementary Health Approaches
Americans spent $30.2 billion on complementary health approaches in a year, according to a recent analysis.
Migraine Patch on Hold for Now
Teva Pharmaceuticals has suspended sales, marketing and distribution for now for the Zecuity (sumatriptan iontophoretic transdermal system) patch.
Got Migraines? Check Your Heart
Women who have been diagnosed with migraines may have a slightly raised risk of heart disease events and heart-related death, a new study found.